JPMORGAN CHASE & CO - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is and the CUSIP is 00972D905. A total of 3 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$2,800,000
+17.2%
1,000,0000.0%0.00%
Q3 2020$2,390,000
-82.4%
1,000,0000.0%0.00%
-100.0%
Q2 2020$13,580,000
+79.2%
1,000,0000.0%0.00%
+50.0%
Q1 2020$7,580,000
+139.9%
1,000,000
+100.0%
0.00%
+100.0%
Q4 2019$3,160,000
-67.6%
500,000
-79.9%
0.00%
-50.0%
Q3 2019$9,761,000
-15.3%
2,490,0000.0%0.00%0.0%
Q2 2019$11,529,000
+41075.0%
2,490,000
+49700.0%
0.00%
Q4 2018$28,000
-36.4%
5,0000.0%0.00%
Q3 2018$44,000
-12.0%
5,0000.0%0.00%
Q2 2018$50,0005,0000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 81,000$29,0000.00%
SIMPLEX TRADING, LLC 225,600$79,0000.00%
JANE STREET GROUP, LLC 47,300$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders